StrokeDx Raises Oversubscribed $5 Million Seed Prime Round to Advance Next-Generation Stroke Technology
StrokeDx, a pioneering stroke technology company, secures funding to develop and commercialize advanced technologies for safe cerebrovascular monitoring. PASADENA, Calif.–(BUSINESS WIRE)–StrokeDx, a pioneer in next-generation stroke technology, today announced the successful closing of $5 million in Series Seed Prime funding.... Read More →
Aureka Biotechnologies and BD Biosciences Commence Project to Accelerate Reagent Antibody Development
Aureka Biotechnologies (“Aureka Bio”), a premier biotech startup in AI-based protein engineering, is thrilled to announce a project with BD (Becton, Dickinson and Company), a leading global medical technology company to harness Aureka Bio’s generative AI-empowered antibody discovery and engineering... Read More →
Why Mark Cuban And Others Are Betting $40 Million On This Under 30 Start Up featuring Genetesis
Cofounders of Genetesis, left to right: Vineet Erasala, Peeyush Shrivastava and Manny Setegn.COURTESY OF GENETESIS Vineet Erasala, Manny Setegn and Peeyush Shrivastava are childhood best friends from Cincinnati, Ohio. They’re also the cofounders of Genetesis—a company that measures signals from... Read More →
RealSeq Biosciences Awarded Patent for Innovative RNA Sequencing Method
SANTA CRUZ, CA, USA, May 21, 2024 /EINPresswire.com/ — RealSeq Biosciences is thrilled to announce that the United States Patent and Trademark Office has awarded the company U.S. Patent No. 11,964,997 B2 for its groundbreaking RNA sequencing technology. This innovative... Read More →
Saving Lives With Limula’s Machine For Industrializing Cell Therapy
“When you’re in the early stages of a gold rush, it makes sense to be the one providing the tools,” says Luc Henry, co-founder of Limula. The Swiss start-up, which is today announcing a $6.8 million funding round, wants to play... Read More →
Oxford Endovascular secures £8 million to take novel brain aneurysm tech to human trials
Parkwalk Advisors led the latest funding round investing £4.2 million alongside Norcliffe Capital, The University of Oxford, Oxford Science Enterprises (OSE) and Vulpes Investment Management. Oxford Endovascular today announces the successful completion of an 8 million GBP Series A+ funding... Read More →
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling featuring CellChorus
Chimeric antigen receptor (CAR) T cells used for the treatment of B cell malignancies can identify T cell subsets with superior clinical activity. Here, using infusion products of individuals with large B cell lymphoma, we integrated functional profiling using timelapse... Read More →
Celldom Lands $938K Phase II SBIR Grant From NCI
NEW YORK – Cell analysis firm Celldom said Tuesday that it has won a $938,647 Phase II Small Business Innovation Research grant from the National Cancer Institute. In an email, CEO and Cofounder Ben Yellen said the grant will fund development of... Read More →
MEACOR Secures $15 Million in Series A Funding to Advance Innovative Transcatheter Heart Valve Repair Technology
BOSTON, May 14, 2024 (GLOBE NEWSWIRE) — MEACOR Inc. is pleased to announce the successful closing of its $15 million Series A funding round. This substantial investment supports MEACOR’s mission to offer a novel transcatheter approach for the treatment of... Read More →
May Health Raises $25 Million in Series B Funding to Advance Development for Ovarian Rebalancing Therapy
– Bpifrance and Trill Impact Ventures co-led the round, joining founding investor Sofinnova Partners, to support the company’s pivotal REBALANCE study evaluating Ovarian Rebalancing in women with infertility caused by PCOS PARIS, May 13, 2024–May Health, a clinical-stage medical device... Read More →